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The overall objective of the study is to estimate the percentage of cancers (excluding non-melanoma skin cancer) in the UK in 2010
that were the result of exposure to 14 major lifestyle, dietary and environmental risk factors: tobacco, alcohol, four elements of diet
(consumption of meat, fruit and vegetables, fibre and salt), overweight, lack of physical exercise, occupation, infections, radiation
(ionising and solar), use of hormones and reproductive history (breast feeding). The number of new cases attributable to suboptimal
exposure levels in the past, relative to a theoretical optimum exposure distribution, is evaluated. For most of the exposures, the
attributable fraction was calculated based on the distribution of exposure prevalence (around 2000), the difference from the
theoretical optimum (by age group and sex) and the relative risk per unit difference. For tobacco smoking, the method developed by
Peto et al (1992) was used, which relies on the ratio between observed incidence of lung cancer in smokers and that in non-smokers,
to calibrate the risk. This article outlines the structure of the supplement – a section for each of the 14 exposures, followed by a
Summary chapter, which considers the relative contributions of each factor to the total number of cancers diagnosed in the UK in
2010 that were, in theory, avoidable.
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The purpose of this study is to estimate the fraction (or
percentage) of cancers occurring in the UK in 2010 that were the
result of exposure to common and, for the most part, modifiable
lifestyle and environmental exposures. A total of 14 major
modifiable lifestyle, dietary and environmental metabolic risks
are considered (Table 1).
The analyses in the chapters that follow estimate the number of
cancer cases diagnosed in the UK in 2010 that were due to such
exposures in the past (or that would have been prevented if risk
factor exposures had been at some hypothetical alternative optimal
distribution from those actually present). The proportion (or
percentage) of such avoidable cancers is known as the population-
attributable fraction (PAF), which provides a quantification of the
total effects of a risk factor (direct, as well as mediated through
other factors).
The inputs to each analysis are as follows:
(1) The aetiological effect of risk factor exposures on cancer-
specific risk.
(2) The population distribution of risk factor exposure in the past
(3) An alternative exposure distribution.
(4) The projected total number of cancer cases (by type) in the UK
population in 2010.
SELECTION OF RISK FACTORS
Among dietary, lifestyle and environmental factors, those that
fulfilled the following criteria were selected:
(i) There was sufficient evidence on the presence and magnitude
of likely causal associations with cancer risk from high-
quality epidemiological studies.
(ii) Data on risk factor exposure were available from nationally
representative surveys.
(iii) There were achievable alternative exposure levels that would
modify the risk.
Several other risk factors were considered but were not included
because the evidence on causal effects was less convincing, or
because their effects on national cancer incidence were likely to
have been small and estimates of relevant past exposures difficult
to obtain. This is discussed further below.
SOURCES OF DATA
(1) The risks of exposure (aetiological effect sizes) were taken
from published systematic reviews and meta-analyses of
epidemiological studies.
(2) Risk factor exposure distributions were obtained from
nationally representative health examination and interview
surveys. Data on prevalence of risk factors from epidemio-
logical studies (cohort or case–control) were not used, as such *Correspondence: Professor DM Parkin; E-mail: d.m.parkin@qmul.ac.uk
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general population of the UK.
(3) The number of cancer cases in 2010 (by cancer type, sex and
5-year age group) was projected using UK incidence rates for
the 15-year period from 1993 to 2007. For such a short-term
projection (3 years), most established methods will provide
very similar results. For all but two cancers (breast and
prostate) the R-based software, ‘Nordpred’ (Møller et al, 2002),
was used to project incidence rates from 2008 to 2012, on the
basis of the incidence rates from 1993 to 2007, aggregated into
three 5-year time periods. National population projections
(2008 based) for the UK by sex, 5-year age group and year,
from 2008 to 2012, were obtained from the population
projections of the Office for National Statistics (Office of
National Statistics (ONS), 2009). The estimate for 2010 was
taken as the average annual number of cases projected for the
period 2008–2012. For cancers of the prostate and female
breast, a different approach was used, because recent rates
have been modified to a great extent by the increased use of
PSA testing and extensions to the breast cancer screening
programme. An age–period cohort model based on observa-
tions for single years was fitted, but incidence rates from age
groups and time periods that were assumed to have been
affected by the introduction of screening were not used in the
model building (Mistry et al, 2011).
Table 2 compares the numbers of cases diagnosed in 2007 with the
projected numbers for 2010.
AETIOLOGICAL EFFECTS OF RISK FACTORS ON
DISEASE-SPECIFIC INCIDENCE
The relative risk (RR) per unit of exposure or for each exposure
category (for risks measured in categories) was obtained for
cancers with probable or convincing causal associations with each
risk factor. The studies used for aetiological effect sizes were
observational studies (prospective cohort studies whenever
possible) that estimated the effects relative to baseline exposure.
The RRs used in the analyses represent the best evidence for the
impact of risk factor exposure on cancer risk in the UK population,
based on the current causes and determinants of the population
distribution of exposure. Relative risks adjusted for major
potential confounders were used to estimate the causal compo-
nents of risk factor–disease associations. With respect to diet, for
example, the relative risks for specific components – for example,
meat – have generally been adjusted for intake of other
components with which they may be confounded, as well as for
total energy intake. However, if there is also a correlation between
exposure and risk of a specific cancer, due to correlations of
exposure with other risks or other unobserved factors, the above
equations may result in under- (when there is positive correlation)
or over-estimation (negative correlation) of the true PAF when
used with adjusted RRs (Bruzzi et al, 1985).
The cancers that occur in a particular year, related to specific
risk factors, are presumably related to cumulative exposures to the
factor concerned over a period of many years. For tobacco
smoking, for example, the risk of lung cancer relates to the
Table 1 Exposures considered, and theoretical optimum exposure level
Exposure Optimum exposure level
Tobacco smoke Nil
Alcohol consumption Nil
Diet
1 Deficit in intake of fruit and vegetables X5 servings (400g) per day
2 Red and preserved meat Nil
3 Deficit in intake of dietary fibre X23g per day
4 Excess intake of salt p6g per day
Overweight and obesity BMI p25kgm
 2
Physical exercise X30min 5times per week
Exogenous hormones Nil
Infections Nil
Radiation – ionising Nil
Radiation – solar (UV) As in 1903 birth cohort
Occupational exposures Nil
Reproduction: breast feeding Minimum of 6 months
Table 2 Numbers of cancers diagnosed in the UK in 2007 (20 most common sites) and estimates for 2010
Males Females
Cancer site 2007 2010 (estimate) Change (%) 2007 2010 (estimate) Change (%)
Breast (female) — — — 45695 48385 6
Lung 22355 22273 0 17118 18132 6
Colorectal cancer 21014 22127 5 17594 17787 1
Prostate 36101 40750 13 — — —
Non-Hodgkin lymphoma 5881 6297 7 5036 5305 5
Malignant melanoma 4975 6095 23 5697 6822 20
Bladder 7284 6713  8 2807 2572  8
Kidney 5165 5697 10 3063 3365 10
Oesophagus 5226 5713 9 2740 2819 3
Stomach 4988 4467  10 2796 2577  8
Pancreas 3748 4084 9 3936 4280 9
Uterus (corpus and unspecified) — — — 7536 8195 9
Leukaemias 4069 4639 14 2932 3201 9
Ovary — — — 6719 6820 2
Oral cavity and pharynx 4083 4571 12 2136 2359 10
Brain and CNS 2663 2799 5 2013 1902  6
Multiple myeloma 2223 2506 13 1817 1994 10
Liver 2152 2270 5 1255 1298 3
Cervix uteri — — — 2828 2691  5
Mesothelioma
a 1977 2077 5 424 462 9
All
b 149356 158667 6 148635 155584 5
aNumber of cases estimated from the UK population (2010) and rates in England in 2008.
bExcluding non-melanoma skin cancer.
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including the time since quitting in ex-smokers. Similarly, the total
lifetime exposure to ionising radiation for individuals in each age
group in 2010 was estimated on the basis of known or estimated
levels of exposure in the past. Such detailed quantification of risk is
not available for most exposures, and, even if it was, it would be
impossible to partition the 2010 UK population according to the
appropriate categories of past exposure. Therefore, for several
exposures, an arbitrary latent period was included, which is the
average interval between ‘exposure’ and the appropriate increase
in risk of the cancers concerned. The most appropriate period was
deemed to be the mean interval between measurement of exposure
and cancer outcome in the prospective studies that were used as
the source of data on relative risks. For most exposures, this was
around 10 years, and thus the effects on cancers occurring in 2010
of suboptimal levels of exposure in 2000 were examined. When
there was evidence about the duration between exposure and
change in risk (for example, for exposure to radiation, or
exogenous and endogenous sex hormones), the appropriate
interval was used to select the year for which exposure data were
obtained. The method used for estimating the attributable fraction
of the most important exposure – tobacco smoking – does not
require estimation on the basis of past exposure, and so no such
assumptions are needed (although, in fact, the latency between
exposure to cigarette smoking and lung cancer risk (at least) is well
documented).
Many calculations of PAFs are based on current levels of exposure
to risk factors; for example, the work of the Global Burden of
Disease/Comparative Risk Assessment Group (Ezzati et al,2 0 0 2 ;
Danaei et al, 2005) or the World Cancer Research Fund (WCRF/
AICR, 2009). Although this simplifies the business of obtaining data
on prevalence of the different exposures, the effect being imputed
must relate to cancers that will be caused by these exposures at some
variable, and undefined, period in the future.
To measure the effects of non-optimal levels of exposure, one
must define, for each exposure, an optimal exposure distribution,
sometimes referred to as the theoretical-minimum-risk exposure
distribution (TMRED), against which the excess risk due to actual
exposure is evaluated. The optimal exposure may be zero for risk
factors for which zero exposure is imaginable, and results in
minimum risk (e.g., no tobacco smoking, alcohol drinking or
consumption of red meat). For some exposures (e.g., BMI, solar
radiation, salt consumption), zero exposure is physiologically
impossible. For these risks, we used optimal exposure levels
corresponding to accepted recommendations for the UK popula-
tion, or, for UV radiation, corresponding to those observed in a
population with an attainable low level of exposure (Table 1). The
‘optimum’ exposure levels for factors with protective effects
(physical activity, and dietary fruit and vegetable and fibre intake)
were selected as the intake and activity levels recommended for the
UK population (Table 1). Strictly speaking, these baselines should
be called ‘recommended levels’, as benefits may continue to accrue
at higher (for preventive exposures) or lower (for carcinogenic
exposures) levels, but the terminology of ‘optimum’ is retained for
consistency. The optimum exposure levels (TMREDs) should
obviously be identical in calculations for the effect of the same
exposure on different cancers.
The fraction of cancer cases considered to be attributable to a
given exposure is based on estimating the effect of bringing all
those individuals at suboptimal levels to the exact level of the
optimum baseline, without changing (improving) the exposure
(and risk) of those individuals who already exceed it. This
approach is a conservative one. In other studies, for example, that
of the WCRF (2009), attributable fractions are based on the
estimated effect of moving all those in suboptimal exposure
categories to the most favourable one (in which the mean exposure
is considerably higher than the optimum baseline).
The analyses use data on the fraction of the UK population at
different levels of exposure, and estimates of the risk associated
with each, relative to the optimum exposure. The PAF is given by
the following equation:
ðp1 ERR1Þþð p2 ERR2Þþð p3 ERR3Þ ... þð pn ERRnÞ
1 þ½ ð p1 ERR1Þþð p2 ERR2Þþð p3 ERR3Þ ... þð pn ERRnÞ 
where px is the proportion of the population in exposure level
x and ERRx the excess relative risk (relative risk 1) at exposure
level x.
The calculation is carried out separately by sex and age group
(the choice of which depended on availability of exposure data).
The method of estimation of PAF follows the same principle for
the different exposures, although some variations to the formula
above are necessary depending on the type of exposure and the
availability of pertinent data; they are presented in detail in each
chapter. For tobacco smoking, the method developed by Peto et al
(1992) was used, which relies on the ratio between observed
incidence of lung cancer in smokers and that in non-smokers, to
calibrate the risk.
Because the current (2010) cancer risk is, for most of the factors
considered, related to past exposures that occur only in adulthood
(age 15þ), or for which data are available only for adults, PAFs
can be calculated only for ages X25, when the latency between
exposure and outcome is 10 years. Even where a fraction of cases
occurring at ages o25 are related to childhood exposure, the effect
of ignoring these on the estimate of the total PAF (at all ages)
will be very small, owing to the rarity of cancer in the age group of
15–24 years.
A separate section is devoted to each lifestyle/environmental
factor, for which the number of cases of different cancers
attributable to suboptimal levels exposure is estimated. This is
expressed also as a percentage of the observed number of cases in
2010. The total number of cancer cases (all sites) attributable to
each risk factor was obtained by summing the numbers at the
individual sites. Cases of different cancers attributable to a single
risk factor are additive because each cancer case is assigned to a
single ICD category.
In a summary chapter, the estimates for the 14 different
exposures are listed together, and the numbers of cancer cases
caused by all of them functioning individually, or in combination,
are estimated.
See acknowledgements on page Si.
Conflict of interest
The author declares no conflict of interest.
REFERENCES
Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C (1985) Estimating the
population attributable risk for multiple risk factors using case-control
data. Am J Epidemiol 122: 904–914
Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M (2005) Causes
of cancer in the world: comparative risk assessment of nine behavioural
and environmental risk factors. Lancet 366: 1784–1793
Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ (2002)
Selected major risk factors and global and regional burden of disease.
Lancet 360: 1347–1360
Mistry M, Parkin DM, Ahmad AS, Sasieni P (2011) Cancer incidence
in the United Kingdom: projections to the year 2030. Br J Cancer 105:
1795–1803
Cancer, lifestyle and environment in the UK in 2010
S4
British Journal of Cancer (2011) 105(S2), S2–S5 & 2011 Cancer Research UKMøller B, Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M,
Haldorsen T (2002) Prediction of cancer incidence in the Nordic
countries up to the year 2020. Eur J Cancer Prev 11(Suppl 1): S1–S96
Office of National Statistics (ONS) (2009) 2008-based National population
projections. http://www.statistics.gov.uk/downloads/theme_population/
NPP2008/NatPopProj2008.pdf
Peto R, Lopez AD, Boreham J, Thun M (1992) Mortality from tobacco in
developed countries: indirect estimation from national vital statistics.
Lancet 339: 1268–1278
World Cancer Research Fund (WCRF)/American Institute for Cancer Research
(AICR) (2009) Policy and Action for Cancer Prevention. Food, Nutrition and
Physical Activity: a Global Perspective.A I C R :W a s h i n g t o n ,D C
This work is licensed under the Creative Commons
Attribution-NonCommercial-Share Alike 3.0 Unported
License. To view a copy of this license, visit http://creativecommons.
org/licenses/by-nc-sa/3.0/
Introduction
S5
British Journal of Cancer (2011) 105(S2), S2–S5 & 2011 Cancer Research UK